Hello. I posted on here a month ago asking for advice before an endo appointment. I was feeling very poorly - a lot of joint pain, brain fog, falling over, dizzy, ears ringing etc. Your advice was really helpful, thank you. I ended up having levothyroxine increased from 50 to 75mcg, liothyrinine left at 10mcg.
Your advice was to request B12, folate, ferritin and vit D tests and come back here with the results.
My GP ordered a comprehensive range of blood tests and I’m posting the results below (long! Sorry). Everything is within reference range. I am still struggling with pain, quite severe dizzy spells, ringing in ears etc.
Thanks in advance if anyone can share any insight xx
Full blood count
Haemoglobin concentration 134.0 g/L [120.0 - 150.0]
Total white blood count 6.6 x10*9/L [4.0 - 10.0]
Platelet count - observation 333 x10*9/L [150.0 - 400.0]
Haematocrit 0.431 [0.36 - 0.46]
Mean cell volume 99.3 fL [83.0 - 101.0]
Red blood cell count 4.34 x10*12/L [3.8 - 4.8]
Mean cell haemoglobin level 30.9 pg [27.0 - 32.0]
Mean cell haemoglobin concentration 311.0 g/L [315.0 - 345.0]
Outside reference range
Neutrophil count 3.72 x10*9/L [2.0 - 7.0]
Lymphocyte count 2.18 x10*9/L [1.0 - 3.0]
Monocyte count - observation 0.60 x10*9/L [0.2 - 1.0]
Eosinophil count - observation 0.09 x10*9/L [0.02 - 0.5]
Basophil count 0.03 x10*9/L [0.02 - 0.1]
Nucleated red blood cell count 0.00 10*9/L
Note: Changes to FBC profile and reference ranges
from 6th April 2017
Erythrocyte sedimentation rate 5 mm/h [3.0 - 15.0]
Serum lipid levels
FASTING STATUS NOT INDICATED. .
Serum cholesterol level 5.5 mmol/L
LIPID GUIDELINES (NICE 2014)
Secondary prevention of CVD: use atorvastatin 80 mg.
(Start with 20 mg if CKD or high risk of interactions)
Primary prevention (inc. T2 DM): atorvastatin 20 mg if
QRISK2 >10%, T1 DM >40 y, CKD +/- albuminuria.
Recheck non-HDL cholesterol at 3/12 aiming for 40% fall
Special cases: high trigs, familial lipids: seek advice
Serum triglyceride levels 1.3 mmol/L [< 1.9]
Serum HDL cholesterol level 1.95 mmol/L [1.1 - 1.6]
Outside reference range
NON-HDL CHOLESTEROL 3.6 mmol/L
Serum cholesterol/HDL ratio 2.8 [< 5.0]
Urea and electrolytes
Serum sodium level 139 mmol/L [135.0 - 145.0]
Serum potassium level 4.2 mmol/L [3.5 - 5.5]
Serum urea level 4.1 mmol/L [2.5 - 6.5]
Serum creatinine level 83 umol/L [55.0 - 100.0]
GFR calculated abbreviated MDRD > 60 ml/min/1.73m2
ESTIMATED GFR FOR CHRONIC KIDNEY DISEASE (CKD)
See guidelines: renal.org/CKDguide/ckd.html
eGFR >60 excludes CKD in the absence of other evidence,
but indicates stage 1/2 CKD if protein-/haematuria, etc
ACUTE KIDNEY INJURY Not applicable
Unable to calculate AKI score: no previous creatinine
LFT
Serum bilirubin level 8 umol/L [< 20.0]
Serum alkaline phosphatase level 99 u/L [35.0 - 104.0]
Serum alanine aminotransferase level 13 u/L [< 45.0]
Serum total protein level 80 g/L [60.0 - 80.0]
Serum albumin level 50 g/L [35.0 - 50.0]
Serum calcium level 2.48 mmol/L
Serum adjusted calcium concentration 2.42 mmol/L [2.2 - 2.65]
Serum globulin level 30 g/L [19.0 - 33.0]
Plasma C-reactive protein level 3 mg/L [< 5.0]
Please note new Reference range from 31/10/17
HbA1c between 6.0 - 6.4% (42 - 47mmol/mol) are consistent with Non-
Diabetic hyperglycaemia (NDH), unless the patient has known diabetes.
HbA1c level (DCCT aligned) 5.6 % of Hb
Haemoglobin A1c level - IFCC standardised 38 mmol/mol [< 48.0]
Serum vitamin B12 level 418 ng/L [190.0 - 910.0]
Serum ferritin level 43 ug/L [10.0 - 291.0]
Ferritin <20 - Iron Deficiency
Ferritin 20 - 30 - Depleted Iron Stores
Please investigate and correct if appropriate
Serum folate level 6.4 ng/mL [3.9 - 26.8]
VITAMIN D 74.8 nmol/L
VITAMIN D GUIDELINES (Total 25-OH Vitamin D, inc D2+D3)
<30 nmol/L Deficiency: High dose treatment and long
term maintenance dose required.
30-50 nmol/L Insufficiency: long term maintenance dose
required
50-75 nmol/L Adequate: lifestyle advice
>75 nmol/L Optimal levels
MENOPAUSAL HORMONE PROFILE
Serum LH level 76.7 u/L
Serum follicle stimulating hormone level 75.7 u/L
Female Ref Ranges: FSH(U/l) LH(U/l) OEST(pmol/l)
Follicular phase 2-10 2-10 130-500
Mid-cycle phase 14-60 520-1470
Luteal phase 2-10 2-10 110-620
Post-menopause >30 >30 <100